Premium Information is available for this item - Upgrade for $1 a day
6505-01-548-3893
Caduet
6505015483893 015483893 0069-215030
January 2023
1
Marketplace 6505-01-548-3893
Request a Quotation from participating marketplace vendors
Related Documents 6505-01-548-3893 5+ Documents (More...)
/fsg-65/fsc-6505/us
Caduet 6505015483893 015483893,0069-215030 ,04-0859 DAC: 4 9 Aug 2007 6505-01-548-3891 Caduet 0069
DAC: 4 9 Aug 2007 6505-01-548-3891 Caduet 0069-218030RNCC: 3 | RNVC: 2 | DAC: 4 21 Feb 2007 6505-01-548-3893
Caduet 6505015483893 015483893,0069-215030 6505-01-548-3893 6505015483893 015483893 CADUET https
/fsg-65/fsc-6505/us
Restrictions 6505-01-548-3893
6505-01-548-3893 is a Caduet that does not have a nuclear hardened feature or any other critical feature such as tolerance, fit restriction or application. Demilitarization of this item has been confirmed and is not currently subject to changes. This item is considered a low risk when released from the control of the Department of Defense. The item may still be subject to the requirements of the Export Administration Regulations (EAR) and the Code of Federal Regulations (CFR). This item may be hazardous as it is in a Federal Supply Class for potentially hazardous items. A MSDS should be available from the supplier for the end user to evaluate any hazards. This item does not contain a precious metal.
End Users 6505-01-548-3893
- Turkey (ZW01)
- Effective Date:
- 1 Feb 2007
Approved Sources 6505-01-548-3893
- Part Number
- Manufacturer
- Status
- 0069-215030
- Manufacturer
- 00YG0 - Pfizer Pharmaceuticals (Active)
- Primary Buy
- Primary Buy
Datasheet 6505-01-548-3893
- Characteristic
- Specifications
- FIIG
- Specifications
- A23900
- Special Features [FEAT]
- Amlodipin Besylate 5 Mg+Atorvastatin 10 Mg; 30 Film Tablet/Blister
NATO Stock Numbers Related to 6505-01-548-3893
Freight Information 6505-01-548-3893
6505-01-548-3893 has freight characteristics managed by Turkey.. 6505-01-548-3893 has a variance between NMFC and UFC when transported by rail and the description should be consulted.